Agilent Technologies Inc.. (4/19/17). "Press Release: Agilent Technologies Presents Thought Leader Award to Professor Dwight Stoll for Separation Science Research". Santa Clara, CA.

	Organisation	Agilent Technologies Inc. (NYSE: A)
	Organisation 2	Gustavus Adolphus College in Saint Peter, Minnesota
	Product	2D-LC technology (two-dimensional liquid chromatography)
	Product 2	biopharmaceutical
	Index term	Gustavus Adolphus College–Agilent: grant, 201704– Thought Leader Award to Dwight Stoll to for 2D-LC research
	Person	Stoll, Dwight (Gastavus Adolphus College, Minnesota 201704 Associate Professor)
	Person 2	Schütte, Stefan (Agilent 200903 Senior Marketing Director Liquid Chromatography Business)

Award Supports International Collaboration on Two-Dimensional Liquid Chromatography

Agilent Technologies Inc. (NYSE: A) announced today that Prof. Dwight Stoll has received an Agilent Thought Leader Award in support of his research applying two-dimensional liquid chromatography (2D-LC) to biopharmaceutical analysis.

An influential researcher in chromatography, Prof. Stoll specializes in multi-dimensional separations, which enables scientists to isolate the components of complex samples with greater ease and clarity.

"I am honored to receive this award, and very excited about Agilent's support of the vision of my laboratory and our collaborators, as we focus on the development of next-generation analytical tools based on 2D-LC for the biopharmaceutical research area," said Prof. Stoll, associate professor of analytical chemistry at Gustavus Adolphus College in Saint Peter, Minnesota.

Prof. Stoll will lead a project on the use of 2D-LC in biopharmaceutical analysis that includes several international experts: Prof. Michael Lämmerhofer of the University of Tuebingen, Germany; Dr. Douglas Richardson of Merck Research Laboratories, Kenilworth, NJ, USA; and Dr. Davy Guillarme of the University of Geneva, Switzerland.

"We are pleased to support Dr. Stoll's research using Agilent's transformative 2D-LC technology, which has the potential to resolve key challenges that biopharmaceutical scientists face when analyzing complex samples," said Dr. Stefan Schuette, vice president and general manager Liquid Phase Separations Division at Agilent Technologies. "The collaborative nature of the research of Dr. Stoll and his international colleagues, combining both academia and industry, will undoubtedly accelerate the progress of these types of solutions for the biopharma industry."

Schuette noted that the high separation power of Agilent's 2D-LC technology makes it ideal for the analysis of highly complex biopharmaceuticals, whether used for comprehensive screening or detailed determination of specific peptides.

The Agilent Technologies Thought Leader Award promotes fundamental scientific advances by contributing financial support, products and expertise to the research of influential thought leaders in the life sciences, diagnostics and applied chemical markets. Information about previous award recipients is available by visiting the Agilent Thought Leader Program web page.

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A), a global leader in life sciences, diagnostics and applied chemical markets, is the premier laboratory partner for a better world. Agilent works with customers in more than 100 countries, providing instruments, software, services and consumables for the entire laboratory workflow. The company generated revenues of $4.20 billion in fiscal 2016 and employs about 12,500 people worldwide. Information about Agilent is available at www.agilent.com.

# # #

Contact:

Victoria Wadsworth-Hansen
Agilent Technologies
+1 408-553-2005
+45 29336980
victoria.wadsworth-hansen@agilent.com

Record changed: 2023-06-05